A Non-Interventional Study of Clinical Characteristics and Mortality of US Patients With Fibrodysplasia Ossificans Progressiva (FOP)
Clinical trial NCT06064656 · COMPLETED
Trial details
- NCT number
- NCT06064656
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2023-06-29
- Primary completion
- 2023-09-22
- Enrollment
- 131
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.